It is a huge honour to be doing this debate under your chairmanship today, Madam Deputy Speaker, and I thank Mr Speaker for granting this debate. Today I would like to update the House on the desperate need for the creation of a new state-of-the-art public health science campus that is fit for the 21st century. This debate is timely as we seek to recover from the devastating covid-19 pandemic that has plagued us for far too long.
In September 2015, the then Chancellor, George Osborne, announced that the Government would be investing £350 million to create world-leading public health laboratories in my constituency of Harlow, Essex. The original intention was for Public Health England’s headquarters and scientific functions to be relocated to our town. I pay special tribute to you, Madam Deputy Speaker, my hard-working constituency neighbour. You are not just a Deputy Speaker, but Dame Eleanor Laing, and you have worked hard with me for a long time on supporting Public Health England. I give thanks to my hon. Friend Alex Burghart, and to my hon. Friend Julie Marson, with whom I share a constituency office. She has done so much on this issue. I know she will be speaking tonight, and I strongly welcome her solid support, as I do yours, Madam Deputy Speaker, for the move of Public Health England’s successor body to Harlow.
I understand that Public Health England is being disbanded and that the organisation is due to be replaced by the newly formed UK Health Security Agency. I have been well assured that this new organisation will also require modernised laboratories. Previous problems have not turned to dust. The current facilities available at Porton Down and Colindale remain exhausted, burned out and ultimately no longer fit for purpose. Significant funding has already been committed to the Harlow site—I understand that the total amount of money spent on project thus far is approaching £250 million.
In a vote of confidence in response to my recent parliamentary question, the Minister explained that a further £120 million-worth of investment has been agreed for the period spanning 2021 to 2022 in Harlow. That shows a real commitment from the Government. I thank the Minister, the Department of Health and Social Care, and in particular the former Health Secretary, my right hon. Friend Matt Hancock, for the continued support for the project and for my constituency of Harlow.
Not only has significant investment taken place, but the plan for the creation of a public health science campus in Harlow is now mature and shovel-ready. Considerable site demolition work has been completed. The buildings have now been stripped to their core and the drainage and power systems are beginning to be installed. Contracts are being drawn up and construction proper could start this year.
In this debate, I would like to outline three reasons why the campus remains necessary and why Harlow is still the best location for the Government’s investment. I am pleased to have met Health Ministers, the Chancellor and senior officials at Public Health England to discuss these matters over the past months. First, the need for updated facilities has become even more important given the current public health context. We must learn lessons from the covid-19 pandemic. We should be looking to the future and onwards to the horizon as we climb down from the coronavirus mountain. We cannot afford to be too cautious. Given that there will be ever-increasing public health spending, the Harlow plant provides excellent value for money. Furthermore, the Harlow project has been designed with the threat of a novel pandemic infection in mind, as has been emphasised on the Government’s own website, which states:
“Early learnings from COVID-19 clearly show the importance of an integrated public health response and the need for rapid sharing of data, information, new laboratory tests and other innovations, coordinated and led from centres like Harlow.”
Those learnings have strengthened the case for the campus, which will place Harlow as one part of the public health system for the development and application of a range of public health interventions. Those can then be adopted across the country.
The construction of a new campus with world-leading laboratory facilities will surely go a long way in improving our resilience and ensuring preparedness for future pandemics. The project will provide a reassuring message for us to give the nation while managing continued uncertainty and scrutiny. This hub could be a shining beacon of hope in the stormy sea from which we are emerging.
Secondly, Harlow’s location within the area covered by the UK Innovation Corridor makes it the ideal place for the creation of such a campus. The London-Stansted-Cambridge corridor is a driver for growth in data sciences as well as life sciences and that sets it off as a unique set of opportunities. Creating the campus in Harlow will mean that our nation’s core microbiology, epidemiology, genomics and data science capabilities will be close to major universities in Cambridge, Essex, Hertfordshire and north London, and the Wellcome Sanger Institute as well as leading life science multinational companies such as GlaxoSmithKline and AstraZeneca. The east of England could be set to become the public health science capital of the world. We could lead the way in research, science and technology.
The importance of the project was even referenced in the UK Innovation Corridor’s submission to the 2020 spending review. It stated:
“The creation of a new public health science campus represents an enormous recognition of the region as being at the forefront of UK science, research and innovation. It is integral to enabling the Innovation Corridor to fully realise its potential in positioning the UK as a scientific superpower.”
In addition, Harlow itself has a tradition of life science and public health investment. The proximity of the campus to the town’s enterprise zones and science park makes Harlow and the science hub the best location for business and research partnerships. The new Harlow hospital, expected by 2025, will also create greater opportunity for health science partnerships, skill sharing and research.
Thirdly, the project will bring significant benefits to the Harlow constituency and surrounding area and fit neatly with the Government’s commitment to level up disadvantaged areas. The Government should be looking to distribute research capacity widely across the UK, rather than concentrating investment in the big capital cities.
Harlow is the second most deprived town in Essex and has some of the most deprived neighbourhoods in the country. Even before the pandemic, jobs, growth and educational attainment had stalled. Much of this is rooted in a new town legacy of ageing infrastructure, poor housing stock and poor perceptions of place, by which I mean disused buildings, some levels of antisocial behaviour and low economic capital. The Government are committed to a levelling-up agenda. I have worked hard to ensure that the Harlow constituency has received great investment. Harlow has been given £81 million for the M11 junction 7a, hundreds of millions for our new Harlow hospital, major investment for our enterprise zone and science park, and most recently £23.7 million as a result of the towns fund bid.
Further to that, Harlow College, one of the finest further education colleges in England, is also bidding, with other colleges in Essex, for a new institute of technology. The bid comes on top of a £2.5 million upgrade of the college and the creation of a £12 million advanced manufacturing centre. Public Health England is also helping to provide skills for Harlow and the surrounding area with its construction hub, which was opened at Harlow College in October 2019. We have further exciting developments taking place, such as the Harlow and Gilston garden town project, which could bring thousands of new homes. It is reliant to an extent upon the creation of a new public health campus in Harlow, as that would bring jobs to sustain this new influx of people.
The creation of a new public health science campus in Harlow would be the golden thread that would tie all this investment together; it is the linchpin upon much else rests. The project represents an opportunity to drive forward Harlow’s growth strategy and address some of the socioeconomic challenges faced by our town and the surrounding areas. The impact that this project will have on Harlow is clear, as it has been estimated that it will create 2,900 gross permanents jobs and generate about £80 million a year across Essex, through employment, skills, STEM— science, technology, engineering and maths—local procurement and support for the local economy.
Madam Deputy Speaker, your place in the Chair tonight signifies your vote of confidence in and hard work for Public Health England. I welcome the Government’s investment in PHE and the vote of confidence of £120 million this year in the Harlow plan. Clearly, things will be different with the new UK Health Security Agency. However, for the reasons I have outlined, the Government could not have made a better decision than by investing in Harlow. First, the public health context and the need for new facilities makes this project ever more crucial. Secondly, Harlow’s location is second to none; our town is part of the innovation corridor and has a long history of life science investment. Thirdly, this project is an essential part of the Prime Minister’s levelling-up agenda and will transform our town by bringing jobs, skills, growth and opportunity.
It is a pleasure to have you in the Chair, Madam Deputy Speaker. It is also a real honour to follow my right hon. Friend Robert Halfon, and I congratulate him on securing this important debate. I commend the argument he has made. The powerful argument does not recognise boundaries; the economic opportunity that he outlines knows no boundaries, including parliamentary boundaries. The economic and strategic benefits of the PHE successor moving to Harlow will also have a powerful benefit in my constituency.
Hertford and Stortford is a beautiful place to live and work, but we too have pockets of deprivation and we too are part of the Government’s levelling-up agenda. We are also building thousands of new homes in the Harlow and Gilston garden town project. The success of that flagship project is so important; as far as I know, it is part of the biggest release of greenbelt land ever. That project is dependent on people and place making—on having skilled jobs for people to do, making it a vibrant new place to live and work.
My constituency is also at the very heart of the Innovation Corridor. As co-chair of the all-party parliamentary group for the Innovation Corridor, I am passionate about the strategic benefits and synergies of siting the public health science campus in this globally renowned cluster for life sciences and healthcare. The corridor is part of an ecosystem and by its very nature every ecosystem is complex; it is not just a case of plonking somewhere down randomly. We need to think about housing, skills and infrastructure. We have all this in the London-Stansted-Cambridge corridor. Harlow is at the heart of that, but so is Hertford and Stortford. We really do want to make the absolute most of the clusters and skills that are at their peak in our part of the Innovation Corridor.
I know that this is part of the Government’s strategic objective to attract investment into our area, particularly foreign direct investment. At the APPG for the Innovation Corridor’s recent annual general meeting, we heard from people in North Carolina and Canada, and asked them, “What are the drivers of success?”. They said that it is about clusters and strategic thinking; that is a crucial part of the success. The campus, with its wider benefits for my constituency, my county and the Innovation Corridor, will be a further step in making the area a scientific global superpower. I commend it to the Minister and again congratulate my right hon. Friend the Member for Harlow on allowing us to have this debate.
I am most grateful to my right hon. Friend Robert Halfon for securing this debate and for driving home so eloquently the three core threads of his argument. I pay tribute to him, to my hon. Friend Julie Marson, and, Madam Deputy Speaker, to you; your passion for your area overflows, and I know that you too have been acting and listening tonight for your constituents in Epping Forest.
Our experience of tackling the covid-19 pandemic has demonstrated, as my right hon. Friend the Member for Harlow said, the fundamental importance of an integrated health response in the United Kingdom. It has illustrated how critical it is to bring together scientific and public health expertise with operational agility. It has underlined the importance of public and private sector collaborations to deliver world-class science and innovation. Getting this right, as my right hon. Friend outlined, is critical to the future security of the nation, and it has arguably required a fundamental rethink of how the public health system and the national health service will work together.
The establishment of the UK Health Security Agency and the Office for Health Promotion are crucial to this new way of working. I am going to focus on the UK HSA, because that is the organisation that has a distinct bearing on what we are talking about this evening. Public health transformation is happening at pace and the UK HSA will be fully operational by October. It will focus on protecting the public’s health and ensuring health security for the nation. It will prevent threats by deploying the UK’s scientific, genomic and analytical capabilities to tackle infectious diseases and public health hazards such as the one we have faced in the past 18 months. It will be science-led, maintain the highest science and research standards and respond to the threats that may come upon us at pace and scale.
Our immediate priority is to manage the current delta variant while working to ensure that UK HSA has solid, firm foundations. Part of that work is to ensure that the underlying operating model for the national science hub is the right one. UK HSA is responsible for the science hub initiative. The principle remains to deliver a step change in public health science and research capabilities with genuinely world-leading facilities that, as the House would expect, we need to ensure are sustainable in every sense of the word.
I am aware that, prior to UK HSA’s creation, one of the key reasons for considering the campus at Harlow was its strategic location, as so eloquently laid out by my right hon. Friend the Member for Harlow and his parliamentary neighbour my hon. Friend the Member for Hertford and Stortford. As we heard, it is wonderfully placed in the east of England, near to major cities and close not only to the vibrant life sciences industry that my right hon. Friend spoke about but to some of the key aspects of academia.
Throughout the UK we currently have a number of leading centres for life science research and innovation. As my right hon. Friend pointed out, the UK Innovation Corridor between London and Cambridge is one of the fastest growing in Europe and something of which we should be proud as a nation. It is widely recognised in the key areas of genomics and data science. With academia, the Wellcome Sanger Institute and leading multinationals we have the rich environment for academic and commercial partnerships to which my right hon. Friend referred. As we have seen in the development of the Oxford-AstraZeneca vaccine, such partnerships are critical to the future success of the public health response here in the United Kingdom.
As a town, Harlow has ambitious plans for the future and for levelling up. As my right hon. Friend said, it has potential to realise. That lies at the heart of the Innovation Corridor, and anchor institutions play a vital role. As my right hon. Friend said, Harlow recently won support worth over £23 million to underpin local regeneration projects. The local garden town development will bring new housing and improved transport. Further Government support is being sought that, if successful, could take investment for Harlow to over £100 million. Alongside that, the Princess Alexandra Hospital in Harlow is at the vanguard, being one of the six hospitals in the Government’s ambitious hospital building programme. There is definitely a bright future for Harlow. The science hub programme is working with my Department to support the transformation in public health. This will take into account learning so far from the pandemic response and the implementation of the UK Health Security Agency.
In conclusion, I congratulate my right hon. Friend the Member for Harlow on his judicious timing of this debate, coming as it does ahead of recess and in the run-up to the official establishment of the UK Health Security Agency in October. I know that his backing for science to be centred in Harlow will be heard and I am sure that we will go on to have further discussions on this interesting topic.
Question put and agreed to.